As shown in Figure 2D, relatively low expression of p-STAT5 and p-CRKL were found in SPOA treated CML cells, which confirmed the degradative effect of SPOA on BCR-ABL in turn. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.